Bevacizumab

Bevacizumab Reactions 1680, p70 - 2 Dec 2017 Spontaneous nasal septum perforation: case report A 34-year-old woman developed spontaneous nasal septum perforation during treatment with bevacizumab [Avastin; route not stated]. The woman, who had a recurrence of breast cancer with multiple lung metastases, started receiving chemotherapy with bevacizumab 10 mg/kg every two weeks. After receiving four cycles of the chemotherapy, she developed irritation and scabbing in the inferior part of the nasal septum along with occasional blood-streaked discharge. The woman initially received nasal hygiene measures and was kept under observation. After receiving two more cycles of bevacizumab, her symptoms had further increased comprising of epistaxis, nasal congestion and rhinorrhea, which led to recurrent nose blowing. Anterior rhinoscopy and clinical check-up by surgeon showed a perforation involving the anterior portion of the nasal septum. The mucosa was found to be dry with visible masses or other abnormalities in the nasal vestibules [outcome not stated]. Author comment: ’’Nasal bleeding s a common side effect of bevacizumab and is usually mild and intermittent. However, nasal septum perforation is rare’’. "As increasing numbers of patients are receiving bevacizumab, oncologists and head and neck surgeon should be aware of this potential complication.’’ Rodriguez CA, et al. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer. Breast Journal 23: 745-746, No. 6, Nov-Dec 2017. Available from: URL: http://doi.org/10.1111/tbj.12913 - Spain 803284712 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Bevacizumab

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/bevacizumab-OwuOzJMjDT
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39001-y
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p70 - 2 Dec 2017 Spontaneous nasal septum perforation: case report A 34-year-old woman developed spontaneous nasal septum perforation during treatment with bevacizumab [Avastin; route not stated]. The woman, who had a recurrence of breast cancer with multiple lung metastases, started receiving chemotherapy with bevacizumab 10 mg/kg every two weeks. After receiving four cycles of the chemotherapy, she developed irritation and scabbing in the inferior part of the nasal septum along with occasional blood-streaked discharge. The woman initially received nasal hygiene measures and was kept under observation. After receiving two more cycles of bevacizumab, her symptoms had further increased comprising of epistaxis, nasal congestion and rhinorrhea, which led to recurrent nose blowing. Anterior rhinoscopy and clinical check-up by surgeon showed a perforation involving the anterior portion of the nasal septum. The mucosa was found to be dry with visible masses or other abnormalities in the nasal vestibules [outcome not stated]. Author comment: ’’Nasal bleeding s a common side effect of bevacizumab and is usually mild and intermittent. However, nasal septum perforation is rare’’. "As increasing numbers of patients are receiving bevacizumab, oncologists and head and neck surgeon should be aware of this potential complication.’’ Rodriguez CA, et al. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer. Breast Journal 23: 745-746, No. 6, Nov-Dec 2017. Available from: URL: http://doi.org/10.1111/tbj.12913 - Spain 803284712 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off